06/23/2017 - 11:43am

The company has looked to the president and CEO of its Purdue Pharma Canada to lead the U.S. business.

06/22/2017 - 4:19pm

The Better Care Reconciliation Act is a 142-page bill that largely mirrors the American Health Care Act that passed the House of Representatives last month, with some key differences. 

06/22/2017 - 3:20pm

Teva’s generic will be available in 75- and 150-mg dosage strengths.

06/22/2017 - 3:12pm

The Food and Drug Administration’s Drug Competition Action Plan begins with a public hearing on July 18 to assess the places where FDA regulations could be creating obstacles to generic access.

06/22/2017 - 1:26pm

Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3x10 blister cards.

06/22/2017 - 10:32am

According to the CDC, American adults are behind on routine annual vaccinations.

06/21/2017 - 3:34pm

The Preserving Patient Access to Compounded Medications Act of 2017 would clarify the Drug Quality and Security Act in a way that would align the statute with congressional intent to balance the issues of public safety and patient access. 

06/20/2017 - 2:48pm

The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.

06/20/2017 - 2:01pm

The drug is indicated as an adjunctive therapy to relieve discomfort associated with acute, painful musculoskeletal conditions.